{"id":142128,"date":"2025-09-16T22:37:10","date_gmt":"2025-09-16T22:37:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/142128\/"},"modified":"2025-09-16T22:37:10","modified_gmt":"2025-09-16T22:37:10","slug":"scottish-hospital-trials-tech-which-can-see-and-treat-lung-cancer","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/142128\/","title":{"rendered":"Scottish hospital trials tech which can ‘see and treat’ lung cancer"},"content":{"rendered":"

\n A clinical trial of the innovative technology behind the treatment has begun at the Royal Infirmary of Edinburgh<\/a>, where up to 40 people will be encouraged to take part. \u00a0\n<\/p>\n

\n The first patient has already been recruited for the trial, which is being run through a partnership with the University of Edinburgh, NHS Lothian and the treatment\u2019s developer Prothea Technologies.\u00a0\u00a0\n<\/p>\n

\n Lung cancer is the third most common cancer in the UK, and nine out of ten patients do not survive more than ten years.\u00a0\n<\/p>\n

\n Currently, patients with suspected early-stage lung cancer undergo screening tests with follow-up scans and biopsies of suspicious tissue. This approach can be slow and can often be inaccurate.\u00a0\n<\/p>\n

\n The Prothea team L-R Jim Stone CTO, Anne Moore COO, Crispin Simon CEO(Image: Nic Delves-Broughton)\n<\/p>\n

\n Prothea\u2019s tech, being used in the trial, allows biopsies to be visualised and tissue taken through a tiny catheter, while an ultrafast imaging and data capture tool offers live insights into the molecular makeup of the lesion. \u00a0\n<\/p>\n

\n This will be combined with a technology that removes the cancerous tissue, making it easier to rapidly spot disease and treat it in the same procedure.\u00a0\n<\/p>\n

\n The team behind Prothea say their technology could alleviate hospital pressures and improve patient outcomes by enabling lung biopsy, diagnosis and treatment to be carried out in a single hospital visit.\u202f\u202f\u00a0\n<\/p>\n

\n The ambitious spinout is the result of over 10 years of hard work and collaboration between the Universities of Edinburgh, Bath, Dundee<\/a> and Durham, alongside NHS Lothian and Heriot-Watt University.\u202f\u00a0\n<\/p>\n

\n Technologies have been developed with support from leading organisations including UK Research and Innovation, the Wellcome Trust and Cancer Research UK.\u00a0\n<\/p>\n

\n Read More:\n<\/p>\n

\n Co-founder and Chief Science and Medical Officer of Prothea and Chair of Molecular Imaging and Healthcare Technology<\/a> at the Institute for Regeneration and Repair, Professor Kev Dhaliwal\u202f previously said: \u201cCollaborations like this demonstrate that universities working together can drive innovation and the economy to ensure the UK stays ahead of the curve on the global tech stage.\u00a0\n<\/p>\n

\n \u201cWe are fortunate to be able to take advantage of the unique benefits Scotland can offer as a location for healthcare research- using real-world data and the collaborative opportunities that exist between the NHS, UK academia, and industry.\u201d\u00a0\n<\/p>\n

\n Dr Adam Marshall, Principal Investigator in the Precision Lung clinical investigation and Consultant Physician in Respiratory Medicine, NHS Lothian, said: \u201cDespite the introduction of many new technologies in recent years there are still patients around the world whose biopsies don\u2019t provide sufficient tissue for the pathology they require. \u00a0\n<\/p>\n

\n \u201cThis novel technology clearly offers something different and I hope that this study will prove to be a satisfactory basis for further clinical investigations.\u201d\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"A clinical trial of the innovative technology behind the treatment has begun at the Royal Infirmary of Edinburgh,…\n","protected":false},"author":2,"featured_media":142129,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[102,2960,56,54,55],"class_list":{"0":"post-142128","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-health","9":"tag-healthcare","10":"tag-uk","11":"tag-united-kingdom","12":"tag-unitedkingdom"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/142128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=142128"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/142128\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/142129"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=142128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=142128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=142128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}